ARTICLE | Company News
Management tracks: Immunocore gains second ex-AZ exec
January 15, 2019 11:46 PM UTC
Immunocore Ltd. (Abingdon, U.K.) said it hired David Berman in September as head of R&D. Berman was SVP and head of immuno-oncology at AstraZeneca plc (LSE:AZN; NYSE:AZN), and before that was head of early stage oncology at the pharma's MedImmune LLC subsidiary. The announcement follows the TCR company's appointment this month of Bahija Jallal as CEO. She was EVP of AstraZeneca and president of MedImmune.
Also this month, AstraZeneca saw the departures of Sean Bohen as CMO and EVP of global medicines and Mark Mallon as EVP of global product and portfolio strategy (see "AZ's Bohen Departing After Cancer-Focused Tenure")...